1,761
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Tripterine and all-trans retinoic acid (ATRA) – loaded lipid-polymer hybrid nanoparticles for synergistic anti-arthritic therapy against inflammatory arthritis

, &
Pages 575-585 | Received 22 Feb 2021, Accepted 27 Jul 2021, Published online: 16 Aug 2021

References

  • Carvalho CS, Andrade LEC, Keusseyan SP, et al. Study of advanced rheumatoid arthritis rev. Bras Eng Biomed. 2014;30:54–63.
  • Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361.
  • O’dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350:2591–2602.
  • Onuora S. Rheumatoid arthritis: vagus nerve stimulation reduces RA severity in patients. Nat Rev Rheumatol. 2016;12(9):500–500.
  • Smolen JS, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol. 2015;11(5):276–289.
  • Pandey S, Rai N, Rawat P, et al. Nanofacilitated synergistic treatment for rheumatoid arthritis: a ‘three-pronged’ approach. Med Hypotheses. 2016;92:44–47.
  • Arora S, Rafiq A, Jolly M. Management of rheumatoid arthritis: review of current guidelines. JAJS. 2016;3(2):45–50.
  • Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861–1874.
  • Ng SW, Chan Y, Chellappan DK, et al. Molecular modulators of celastrol as the keystones for its diverse pharmacological activities. Biomed Pharmacother. 2019;109:1785–1792.
  • Dai W, Wang X, Teng H, et al. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Int Immunopharmacol. 2019;66:215–223.
  • Qi X, Qin J, Ma N, et al. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation. Int J Pharm. 2014;472(1–2):40–47.
  • Song J, Shi F, Zhang Z, et al. Formulation and evaluation of celastrol-loaded liposomes. Molecules. 2011;16(9):7880–7892.
  • Freag MS, Saleh WM, Abdallah OY. Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol. Int J Pharm. 2018;535(1–2):18–26.
  • Li W, Zhang T, Ye Y, et al. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material. Int J Pharm. 2015;495(2):948–955.
  • Cao X, Hu Y, Luo S, et al. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sin B. 2019;9(3):575–589.
  • Choi JY, Gupta B, Ramasamy T, et al. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors. Colloids Surf B Biointerfaces. 2018;165:56–66.
  • Guo L, Luo S, Du Z, et al. Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat Commun. 2017;8(1):878.
  • Zhao Y, Tan Y, Meng T, et al. Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles . Drug Deliv. 2018;25(1):341–352.
  • Ramasamy T, Ruttala HB, Gupta B, et al. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review. J Control Release. 2017;258:226–253.
  • Ramasamy T, Munusamy S, Ruttala HB, et al. Smart nanocarriers for the delivery of nucleic acid-based therapeutics: a comprehensive review. Biotechnol J. 2021;16(2):e1900408.
  • Ruttala HB, Ramasamy T, Poudel BK, et al. Multi-responsive albumin-lonidamine conjugated hybridized gold nanoparticle as a combined photothermal-chemotherapy for synergistic tumor ablation. Acta Biomater. 2020;101:531–543.
  • Kwok SK, Park MK, Cho ML, et al. Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol. 2012;189(2):1062–1071.
  • Racke MK, Burnett D, Pak SH, et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol. 1995;154(1):450–458.
  • Hong K, Zhang Y, Guo Y, et al. All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling. Immunol Lett. 2014;162(1 Pt A):34–40.
  • Li F, Zhao X, Wang H, et al. Multiple layer-by-Layer Lipid-Polymer hybrid nanoparticles for improved FOLFIRINOX chemotherapy in pancreatic tumor models. Adv Funct Mater. 2015;25(5):788–798.
  • Mukherjee A, Waters AK, Kalyan P, et al. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019;14:1937–1952.
  • Zhang W, Wang Z, Wu C, et al. The effect of DSPE-PEG2000, cholesterol and drug incorporated in bilayer on the formation of discoidal micelles. Eur J Pharm Sci. 2018;125:74–85.
  • Liu Y, Zhou C, Wei S, et al. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Colloids Surf B Biointerfaces. 2018;170:330–340.
  • Chen Y, Qu D, Fu R, et al. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment. Int J Nanomedicine. 2018;13:7275–7287.
  • Payne CM, Burke LP, Cavanagh B, et al. Evaluation of the immunomodulatory effects of All-Trans retinoic acid solid lipid nanoparticles and human mesenchymal stem cells in an A549 epithelial cell line model. Pharm Res. 2019;36(4):50.
  • Du Y, Song Y, Zhang L, et al. Combined treatment with low dose prednisone and escin improves the anti-arthritic effect in experimental arthritis. Int Immunopharmacol. 2016;31:257–265.
  • Zhao J, Luo D, Zhang Z, et al. Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice. J Control Release. 2019;310:188–197.
  • Li P, Yang X, Yang Y, et al. Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice. J Control Release. 2020;319:87–103.
  • Pino-Lagos K, Guo Y, Noelle RJ. Retinoic acid: a key player in immunity. Biofactors. 2010;36(6):430–436.
  • Bazile D, Prud’homme C, Bassoullet MT, et al. Stealth me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci. 1995;84(4):493–498.
  • Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv. 2011;8(3):343–357.
  • Guerrini L, Alvarez-Puebla RA, Pazos-Perez N. Surface modifications of nanoparticles for stability in biological fluids. Materials. 2018;11:1154.
  • Li C, Li H, Wang Q, et al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J Control Release. 2017;246:133–141.
  • Wang D, Miller SC, Liu X, et al. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res. Ther. 2007;9:1–9.
  • Andersson SE, Lexmüller K, Johansson A, et al. Tissue and intracellular pH in normal periarticular soft tissue and during different phases of antigen induced arthritis in the rat. J Rheumatol. 1999;26(9):2018–2024.
  • Goetzi EJ, Rynes RI, Stillman JS. Abnormalities of respiratory gases in synovial fluid of patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1974;17(4):450–454.
  • Ruttala HB, Ramasamy T, Ruttala RRT, et al. Mitochondria-targeting multi-metallic ZnCuO nanoparticles and IR780 for efficient photodynamic and photothermal cancer treatments. Journal of Materials Science & Technology. 2021;86:139–150.
  • Choi JK, Oh H-M, Park JH, et al. Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis. Phytomedicine. 2015;22(3):415–422.
  • Xue M, Jiang ZZ, Wu T, et al. Anti-inflammatory effects and hepatotoxicity of tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats. Phytomedicine. 2012;19(11):998–1006.
  • Kim JL, Kang SW, Kang MK, et al. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. J Cell Biochem. 2012;113(1):247–259.
  • Ha YJ, Lee SM, Mun CH, et al. Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):146.
  • Jokerst JV, Lobovkina T, Zare RN, et al. Nanoparticle PEGylation for imaging and therapy. Nanomedicine. 2011;6(4):715–728.
  • Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156(4):1363–1380.
  • Baluk P, Hirata A, Thurston G, et al. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol. 1997;272(1 Pt 1):L155–L170.
  • Decuzzi P, Pasqualini R, Arap W, et al. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 2009;26(1):235–243.
  • Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344(12):907–916.
  • Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103(9):1345–1352.
  • Gupta G, Dahiya R, Singh M, et al. Role of liraglutide in a major complication of diabetes: a critical review of clinical studies. Bull Pharm Res. 2018;8(1):155–164.44.
  • Gupta G, Dua K, Kazmi I, et al. Anticonvulsant activity of Morusin isolated from Morus Alba: Modulation of GABA receptor. Biomed Aging Pathol. 2014;4(1):29–32.
  • Li Q, Verma IM. NF-kappaB regulation in the immune system . Nat Rev Immunol. 2002;2(10):725–734.
  • Salama AH, Abdelkhalek AA, Elkasabgy NA. Etoricoxib-loaded bio-adhesive hybridized polylactic acid-based nanoparticles as an intra-articular injection for the treatment of osteoarthritis. Int J Pharm. 2020;578:119081.
  • Hsiao HB, Hsieh CC, Wu JB, et al. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses. BMC Complement Altern Med. 2016;16:80.
  • Shi Q, Cao J, Fang L, et al. Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-κB, MAPK and AP-1 signaling pathways in macrophages. Int Immunopharmacol. 2014;20(2):298–306.